Literature DB >> 1682864

Effects of IL-3 on promoter usage, attenuation and antisense transcription of the c-myc oncogene in the IL-3-dependent Ba/F3 early pre-B cell line.

Y Chang1, D B Spicer, G E Sonenshein.   

Abstract

The c-myc gene uses two major promoters, P1 and P2, for production of mRNA. In most proliferating normal cells, transcripts initiated from P2 predominate over the ones from P1. Furthermore, transcription of normal and translocated c-myc genes is bidirectional and overlapping. In this study, we have measured the effects of interleukin 3 (IL-3) deprivation and restimulation on c-myc promoter usage in the IL-3-dependent pre-B cell line Ba/F3. The rapid drop in c-myc mRNA expression observed in Ba/F3 cells upon IL-3 deprivation is reversible upon restimulation with interleukin. The use of P1 and P2 promoters, as judged by P1/P2 ratio, shifted from 0.2 in cells in exponential growth or in quiescence to 1.3 following IL-3 stimulation. This change was not due to selective instability of one of the two myc transcripts. In vitro nuclear run-on experiments indicated that IL-3 addition resulted in a large release of transcriptional attenuation, as well as a significant increase in transcriptional initiation. These results are consistent with the hypothesis that P1/P2 promoter usage is involved in the control of transcriptional elongation. Furthermore, deprivation of IL-3 resulted in a dramatic increase in antisense transcription, whereas little change was observed in the rate of initiation of elongation of c-myc mRNA precursors. This correlation suggests a negative role for antisense transcription in expression of c-myc mRNA levels in IL-3-deprived Ba/F3 cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682864

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  An antisense promoter of the murine c-myc gene is localized within intron 2.

Authors:  D B Spicer; G E Sonenshein
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

2.  Highly expressed genes are associated with inverse antisense transcription in mouse.

Authors:  Andras Györffy; Pawel Surowiak; Zsolt Tulassay; Balazs Györffy
Journal:  J Genet       Date:  2007-08       Impact factor: 1.166

Review 3.  In vitro and in vivo action of antisense RNA.

Authors:  W Nellen; G Sczakiel
Journal:  Mol Biotechnol       Date:  1996-08       Impact factor: 2.695

Review 4.  Making (anti)sense of non-coding sequence conservation.

Authors:  D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-15       Impact factor: 16.971

5.  You Don't Muck with MYC.

Authors:  David Levens
Journal:  Genes Cancer       Date:  2010-06-01

Review 6.  Antisense RNA: function and fate of duplex RNA in cells of higher eukaryotes.

Authors:  M Kumar; G G Carmichael
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

7.  Repeated CT elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters.

Authors:  E DesJardins; N Hay
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

8.  Distinct properties of c-myc transcriptional elongation are revealed in Xenopus oocytes and mammalian cells and by template titration, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB), and promoter mutagenesis.

Authors:  T Meulia; A Krumm; M Groudine
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

9.  Sequences in the human c-myc P2 promoter affect the elongation and premature termination of transcripts initiated from the upstream P1 promoter.

Authors:  T Meulia; A Krumm; C Spencer; M Groudine
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

10.  Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma.

Authors:  Cristina López; Kortine Kleinheinz; Sietse M Aukema; Marius Rohde; Stephan H Bernhart; Daniel Hübschmann; Rabea Wagener; Umut H Toprak; Francesco Raimondi; Markus Kreuz; Sebastian M Waszak; Zhiqin Huang; Lina Sieverling; Nagarajan Paramasivam; Julian Seufert; Stephanie Sungalee; Robert B Russell; Julia Bausinger; Helene Kretzmer; Ole Ammerpohl; Anke K Bergmann; Hans Binder; Arndt Borkhardt; Benedikt Brors; Alexander Claviez; Gero Doose; Lars Feuerbach; Andrea Haake; Martin-Leo Hansmann; Jessica Hoell; Michael Hummel; Jan O Korbel; Chris Lawerenz; Dido Lenze; Bernhard Radlwimmer; Julia Richter; Philip Rosenstiel; Andreas Rosenwald; Markus B Schilhabel; Harald Stein; Stephan Stilgenbauer; Peter F Stadler; Monika Szczepanowski; Marc A Weniger; Marc Zapatka; Roland Eils; Peter Lichter; Markus Loeffler; Peter Möller; Lorenz Trümper; Wolfram Klapper; Steve Hoffmann; Ralf Küppers; Birgit Burkhardt; Matthias Schlesner; Reiner Siebert
Journal:  Nat Commun       Date:  2019-03-29       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.